Madopar

Levodopa, the active ingredient in Madopar, is a dopamine precursor presented as oral tablets for oral use. It is combined with benserazide hydrochloride to treat Parkinson's disease and Parkinsonian syndrome in adult patients. GNH USA supplies Madopar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Madopar, a dopamine precursor with a decarboxylase inhibitor, is used to manage disorders of the dopaminergic system. - Parkinson's disease: improves motor control and reduces rigidity, tremor, and bradykinesia. - Parkinsonian syndrome: alleviates secondary Parkinsonism symptoms, enhancing mobility. - Motor fluctuations (wearing‑off): helps manage end‑of‑dose deterioration in patients on long‑term therapy.

Adverse reactions may occur with Madopar and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional, often related to rapid dose escalation. - Dizziness: may be postural, especially after first doses. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient, usually resolves with continued therapy. - Insomnia: difficulty initiating or maintaining sleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary movements that can become disabling. - Psychiatric disturbances: hallucinations, confusion, or mood changes. - Severe hypotension: marked blood pressure reduction requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals. - Neuroleptic malignant syndrome: rare but life‑threatening reaction.

When prescribing Madopar, clinicians should consider several safety measures. - Dose titration: start low and increase gradually to balance efficacy and tolerability. - Monitor for dyskinesia: adjust dose if involuntary movements develop. - Assess renal and hepatic function: impaired clearance may require dose modification. - Avoid abrupt discontinuation: taper to prevent withdrawal and worsening symptoms. - Take with food: reduces gastrointestinal irritation. - Store at ambient temperature: keep in the original container, protect from moisture.

Madopar may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - High‑dose MAO‑B inhibitors (e.g., selegiline): may increase levodopa plasma levels. - Iron or calcium supplements: reduce levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure lowering effect. - SSRIs or SNRIs: potential for serotonin syndrome. - High‑protein meals: compete for transport and lower central availability.